Effects of long-term (for 5 years) treatment using pravastatin sodium on hyperlipidemia in diabetics

被引：0
|
作者：
Komori, H [1 ]
Oi, K [1 ]
机构：
[1] TOHO UNIV,OHASHI HOSP,DEPT DIABETOL,TOKYO,JAPAN
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88688-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [1] Escape phenomenon with pravastatin during long-term treatment of patients with hyperlipidemia associated with diabetes mellitus
    Oi, K
    Komori, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (02): : 130 - 138
  • [2] Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia
    Iliadis, EA
    Rosenson, RS
    CLINICAL CARDIOLOGY, 1999, 22 (01) : 25 - 28
  • [3] Escape phenomenon during the long-term administration of pravastatin for hyperlipidemia associated with diabetes
    Oi, K
    Komori, H
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 127 - 127
  • [4] RESULTS OF SURGERY - LONG-TERM EFFECTS ON HYPERLIPIDEMIA
    GLEYSTEEN, JJ
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 55 (02): : 591 - 593
  • [5] LONG-TERM CAPD TREATMENT - 5 YEARS EXPERIENCE
    SELGAS, R
    FONTAN, P
    HUARTE, E
    MUNOZ, J
    SANZ, A
    MIGUEL, JL
    TORRE, A
    MARA, J
    SSICILIA, L
    KIDNEY INTERNATIONAL, 1986, 30 (01) : 132 - 132
  • [6] ANTIHYPERTENSIVE TREATMENT OF LONG-TERM DIABETICS WITH NIFEDIPINE
    HASCHE, H
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1985, 127 (19): : 495 - 498
  • [7] LONG-TERM TREATMENT OF HYPERCHOLESTEROLEMIC NON-INSULIN DEPENDENT DIABETICS (NIDDM) WITH PRAVASTATIN (CS-514)
    YOSHINO, G
    KAZUMI, T
    IWAI, M
    MATSUSHITA, M
    MATSUBA, K
    UENOYAMA, R
    IWATANI, I
    BABA, S
    ATHEROSCLEROSIS, 1989, 75 (01) : 67 - 72
  • [8] EFFICACY, SAFETY, AND TOLERABILITY OF PRAVASTATIN FOR THE LONG-TERM TREATMENT OF PATIENTS WITH DIVERSE TYPES OF HYPERLIPIDEMIA - A MULTICENTER PROSPECTIVE-STUDY
    KATOH, K
    MIZUNO, K
    NIIMURA, S
    FUKUCHI, S
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 54 (05): : 500 - 507
  • [9] Effects of long-term (up to 5 years) open-label treatment with aripiprazole
    Kungel, M
    Ebrecht, M
    Modell, S
    Werner, C
    Spevakné-Göröcs, T
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 257 - 257
  • [10] HEPATOXICITY WITH LONG-TERM TREATMENT OF HYPERLIPIDEMIA WITH NIACIN AND LOVASTATIN
    MATARAZZO, M
    DEPACE, N
    CLINICAL RESEARCH, 1992, 40 (02): : A272 - A272
12345